INS and Other metabolic disease: IH may induce metabolic disorders by impairing pancreatic β-cell function, causing inflammatory responses in adipose tissue, and increasing glucose production in the liver, which interferes with insulin signaling pathways and disrupts glucose metabolism (19, 20).